Related Experiment Video
Updated: Jul 18, 2026
09:38
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination
Yoko Warabi1, Yoh Matsumoto, Hideaki Hayashi
1Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan. ywarabi@tmnh.fuchu.tokyo.jp
Journal of the Neurological Sciences
|November 28, 2006
Summary
Interferon beta-1b (IFNB-1b) is ineffective for patients with demyelinating diseases mimicking neuromyelitis optica (NMO), especially those with the HLA DPB1*0501 allele. These patients experience relapses and side effects, suggesting an NMO diagnosis is more appropriate.
Area of Science:
- Neuroimmunology
- Clinical Neurology
- Genetics
Background:
- Multiple sclerosis (MS) and neuromyelitis optica (NMO) are distinct central nervous system demyelinating diseases.
- Genetic factors, such as HLA DPB1*0501, are associated with increased NMO risk, particularly in Japanese populations.
- MS with severe optic-spinal demyelination shares clinical and genetic features with NMO.
Purpose of the Study:
- To evaluate the efficacy of interferon beta-1b (IFNB-1b) in patients with demyelinating diseases.
- To investigate the relationship between IFNB-1b treatment outcomes and clinical/genetic characteristics in MS, NMO, and related conditions.
- To differentiate between MS and NMO based on clinical presentation and genetic markers.
Main Methods:
- Retrospective analysis of patients with demyelinating diseases.
- Examination of clinical data including optic nerve and spinal cord lesions, blindness, and cerebrospinal fluid (CSF) pleocytosis.
- Genetic analysis for HLA DPB1*0501 allele presence.
- Assessment of IFNB-1b treatment response and side effects.
Main Results:
- Japanese MS patients frequently carried the HLA DPB1*0501 allele, associated with NMO.
- MS patients with HLA DPB1*0501 exhibited severe optic-spinal demyelination, including longitudinally extensive spinal cord lesions and blindness.
- IFNB-1b treatment was ineffective in these patients, leading to increased relapses and adverse events.
Conclusions:
- IFNB-1b should not be administered to patients presenting with NMO-like clinical and genetic profiles (HLA DPB1*0501, severe optic-spinal lesions, blindness, CSF pleocytosis), even with MS-typical cerebral lesions.
- Patients with these characteristics should be diagnosed with NMO rather than MS.
- Accurate diagnosis is crucial for appropriate treatment selection in demyelinating diseases.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...